GE HealthCare (Nasdaq:GEHC) introduced that its MIM Software program unit started rolling out its new MIM Symphony HDR Prostate answer.
MIM Symphony HDR helps excessive dose-rate (HDR) brachytherapy with direct tumor visualization from MRI scans throughout dwell ultrasound procedures for HDR prostate remedies. The know-how corrects MRI orientation and presents MRI steering throughout HDR prostate procedures. It goals to extend clinician confidence and assist enhance affected person outcomes.
HDR brachytherapy, a prostate most cancers therapy, entails implanting radioactive sources into the prostate gland by way of needles. Clinicians sometimes use computed tomography (CT) or ultrasound for planning these procedures. Utilizing MRI can scale back toxicity to essential buildings, GE HealthCare stated in a information launch. Nonetheless, the problem of precisely aligning MRI contours with dwell ultrasound hinders using MRI in HDR remedies.
MIM Symphony HDR aligns contours on preoperatively acquired MRI with dwell ultrasound. It supplies clear visibility of the prostate, lesions and demanding buildings.
This new answer provides to GE HealthCare’s MIM Software program portfolio of vendor-neutral options for radiation oncology. The corporate introduced the software program into its portfolio via an acquisition of MIM Software program in April.
“Our purpose with this answer is to empower clinicians to plan and ship protected, extra knowledgeable, and exact therapy for sufferers with prostate illness,” stated Andrew Nelson, CEO of MIM Software program, GE HealthCare. “MIM Symphony HDR Prostate exemplifies many years of MIM Software program and GE HealthCare improvements that allow precision care, and we’re thrilled to increase our affect in brachytherapy.”
